Comprehensive Geriatric Assessment (CGA) in qualification for palliative chemotherapy Case report

##plugins.themes.bootstrap3.article.sidebar##

PDF (English)


Opublikowane: wrz 30, 2019
DOI: https://doi.org/10.24292/01.OR.319260619
Słowa kluczowe:
geriatric oncology, Comprehensive Geriatric Assessment, CGA

##plugins.themes.bootstrap3.article.main##

Katarzyna Kryszczyszyn-Musialik
1. Oncology Department with Hematological Subdivision, Provincial Specialist Hospital No. 3 in Rybnik. 2. Chair and Department of Environmental Medicine and Epidemiology, Medical University of Silesia in Katowice.
Grzegorz Słomian
Oncology Department with Hematological Subdivision, Provincial Specialist Hospital No. 3 in Rybnik
Jadwiga Jośko-Ochojska
Chair and Department of Environmental Medicine and Epidemiology, Medical University of Silesia in Katowice

Abstrakt

More than a half of new cancer cases affects elderly people. The number of patients in that group is constantly raising. Geriatric patients with cancer are very ununiform group with their biological age, comorbidities and conditions. The risk of the treatment’s toxicity in that group is increased due to loss of organ reserves. Based not only on metrical age or performance status but using precise assessment aids with choosing proper treatment this lowers the complication rate. Comprehensive Geriatric Assessment (CGA) is a multidimensional tool that helps assess elderly patients including daily living, physical status, cognitive functions, depression, nutrition and comorbidities. The following describes utility of CGA in 77-year-old male with colon cancer being qualified for palliative chemotherapy.

Pobrania

Dane pobrania nie są jeszcze dostepne

##plugins.generic.paperbuzz.metrics##

##plugins.generic.paperbuzz.loading##

##plugins.themes.bootstrap3.article.details##

Jak cytować
1.
Kryszczyszyn-Musialik K, Słomian G, Jośko-Ochojska J. Comprehensive Geriatric Assessment (CGA) in qualification for palliative chemotherapy. OncoReview [Internet]. 30 wrzesień 2019 [cytowane 23 listopad 2024];9(3(35):64-7. Dostępne na: https://journalsmededu.pl/index.php/OncoReview/article/view/1089
Numer
Tom 9 Nr 3(35) (2019)
Dział
CARDIO-ONCOLOGY
Creative Commons License

Utwór dostępny jest na licencji Creative Commons Uznanie autorstwa – Użycie niekomercyjne – Bez utworów zależnych 4.0 Międzynarodowe.

Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)

Bibliografia

1. Balducci L. Epidemiology of cancer and aging. J Oncol Manag 2005; 14: 4750.
2. Wojciechowska U, Didkowska J. Zachorowania i zgony na nowotwory złośliwe w Polsce. Krajowy Rejestr Nowotworów, Centrum Onkologii – Instytut im. Marii Skłodowskiej-Curie. Online: http://onkologia.org.pl/raporty/. Dostęp: 18.02.2019.
3. Krzemieniecki K. Całościowa ocena geriatryczna i jej znaczenie kliniczne w onkologii – systematyczny przegląd piśmiennictwa. Gerontol Pol 2009; 17(1): 1-6.
4. Extermann M. Geriatric Assessment for Focus on instrument selectivity for outcomes. Cancer 2005; 11: 474-80.
5. Papamichael D, Audisio RA, Glimelius B et al. Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013. Ann Oncol 2015; 26(3): 463-76.
6. Katz S, Ford AB, Moskowitz RW et al. W. Studies of illness in the aged. The index of ADL: A standardized measure of biological and psychosocial function. JAMA 1963; 185: 914-9. https://doi.org/10.1001/jama.1963.03060120024016.
7. Vellas B, Villars H, Abellan G et al. Overview of the MNA® – Its History and Challenges. J Nutr Health Aging 2006; 10: 456-65.
8. Rubenstein LZ, Harker JO, Salva A et al. Screening for Undernutrition in Geriatric Practice: Developing the Short-Form Mini Nutritional Assessment (MNA-SF). J Geront 2001; 56A: M366-77.
9. Guigoz Y. The Mini-Nutritional Assessment (MNA®) Review of the Literature – What does it tell us? J Nutr Health Aging 2006; 10: 466-87.
10. Rivolta MW, Aktaruzzaman M, Rizzo G et al. Evaluation of the Tinetti score and fall risk assessment via accelerometry-based movement analysis. Artif Intell Med 2019; 95: 38-47. https://doi.org/10.1016/j.artmed.2018.08.005.
11. Tinetti ME, Williams TF, Mayewski R. Fall risk index for elderly patients based on number of chronic disabilities. Am J Med 1986; 80: 429-34.
12. Hodkinson HM. Evaluation of a Mental Test Score for assessment of mental impairment in the elderly. Age Ageing 1972; 1: 233-8.
13. Yesavage J, Brink TL, Rose TL et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1983; 17: 37-49.
14. Miller MD, Paradis CF, Houck PR et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 1992; 41(3): 237-48.
15. Rodin MB, Mohile SG. A practical approach to geriatric assessment in oncology. J Clin Oncol 2007; 25: 1936-44.
16. Sorbye H, Pfeiffer P, Cavalli-Bjorkman N et al. Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients. Cancer 2009; 115: 4679-87.
17. Repetto L. Greater risks of chemotherapy toxicity in elderly patients with cancer. J Support Oncol 2003; 1(suppl 2): 18-24.